VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P29
Within normal range
vs 5Y Ago
-4.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-75.12%
202450.44%
2023-24.05%
2022-166.32%
202113.67%
202015.52%
2019-71.41%
2018-39.88%
201778.28%
2016-240.06%